Ebola Virus Disease

Ebola, also known as Ebola hemorrhagic fever or Ebola viral disease, is a rare and deadly illness caused by one of the strains of Ebola virus. This viral agent is regarded as a prototype pathogen of viral hemorrhagic fever, with high fatality rates in humans and primates.

Overview

Feature Articles

Latest Ebola Virus Disease News and Research

Scientists identify a promising strategy for stopping Ebola virus polymerase

Scientists identify a promising strategy for stopping Ebola virus polymerase

Foundational characterization of a new bat-borne ebolavirus and its potential as a human pathogen

Foundational characterization of a new bat-borne ebolavirus and its potential as a human pathogen

Persistent Ebola virus can hide in the brain and re-emerge to cause fatal disease

Persistent Ebola virus can hide in the brain and re-emerge to cause fatal disease

Paxlovid provides a glimpse into the future against SARS-CoV-2

Paxlovid provides a glimpse into the future against SARS-CoV-2

Study identifies cellular receptors for alphaviruses shared across mosquitoes, humans, and animals

Study identifies cellular receptors for alphaviruses shared across mosquitoes, humans, and animals

University of Oxford begins Phase I trial to test Ebola vaccine

University of Oxford begins Phase I trial to test Ebola vaccine

Analysis of 2021 Ebola outbreak reveals long-term dormant infections

Analysis of 2021 Ebola outbreak reveals long-term dormant infections

New study reveals unique immune responses to SARS-CoV-2, Ebola and respiratory syncytial virus using B cell repertoire analysis

New study reveals unique immune responses to SARS-CoV-2, Ebola and respiratory syncytial virus using B cell repertoire analysis

Cote d’Ivoire declares the country’s first case of Ebola since 1994

Cote d’Ivoire declares the country’s first case of Ebola since 1994

How to run a COVID-19 vaccination campaign: lessons from other infectious outbreaks

How to run a COVID-19 vaccination campaign: lessons from other infectious outbreaks

Investigation reveals considerable added benefit of remdesivir for moderately ill COVID-19 patients

Investigation reveals considerable added benefit of remdesivir for moderately ill COVID-19 patients

Texas Biomed scientists receive $1 million NIH funding for Ebola research

Texas Biomed scientists receive $1 million NIH funding for Ebola research

Newly-discovered bat coronavirus 94.5% identical to SARS-CoV-2

Newly-discovered bat coronavirus 94.5% identical to SARS-CoV-2

Despite strict COVID-19 measures, public trust in UK government has mixed response

Despite strict COVID-19 measures, public trust in UK government has mixed response

Researchers identify a pathway used by filoviruses to enter cells

Researchers identify a pathway used by filoviruses to enter cells

Polyclonal SARS-CoV-2 antibody shows potent neutralizing activity in vitro

Polyclonal SARS-CoV-2 antibody shows potent neutralizing activity in vitro

COVID-19 pandemic and nanotechnology

COVID-19 pandemic and nanotechnology

Standard decontamination technologies can remove or inactivate all viruses from drinking water

Standard decontamination technologies can remove or inactivate all viruses from drinking water

Study could help understand mechanisms of drug molecules to mitigate COVID-19 infection

Study could help understand mechanisms of drug molecules to mitigate COVID-19 infection

Johnson & Johnson SARS-CoV-2 vaccine shows promise in clinical trials

Johnson & Johnson SARS-CoV-2 vaccine shows promise in clinical trials